Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health

Experimental Biology and Medicine

Volumn 230, Issue 3, 2005, Pages 155-170

  Atkinson, Charlotte ^a   Frankenfeld, Cara L ^a   Lampe, Johanna W ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Daidzein; Equol; Intestinal microbiota; Isoflavone; O desmethylangolensin; Soy

Indexed keywords

DAIDZEIN; EQUOL; GENISTEIN; ISOFLAVONE; O DESMETHYLANGOLENSIN; PHYTOESTROGEN; UNCLASSIFIED DRUG;

BACTERIAL METABOLISM; BACTEROIDES OVATUS; BIFIDOBACTERIUM; BINDING AFFINITY; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CLOSTRIDIUM; DISEASE PREDISPOSITION; DRUG POTENCY; ESCHERICHIA COLI; EUBACTERIUM; HEALTH; HUMAN; IN VITRO STUDY; INTESTINE FLORA; MENOPAUSAL SYNDROME; NONHUMAN; OSTEOPOROSIS; PHENOTYPE; PROSTATE CANCER; RUMINOCOCCUS; SHORT SURVEY; STREPTOCOCCUS INTERMEDIUS;

ANIMALIA; BACTERIA (MICROORGANISMS); MICROBIOTA;

EID: 14344267019     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020523000302     Document Type: Short Survey

References (138)

1. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 361:512-519, 2003.
2. Puupponen-Pimia R, Aura AM, Karppinen S, Oksman-Caldentey KM, Poutanen K. Interactions between plant bioactive food ingredients and intestinal flora - effects on human health. Biosci Microflora 23:67-80, 2004.
3. Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol 4:430-435, 1996.
4. Tannock GW. The normal microflora: an introduction. In: Tannock GW, Ed. Medical Importance of the Normal Microflora. Dordrecht, the Netherlands: Kluwer Academic Press, ppl-23, 1999.
5. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31:107-133, 1977.
6. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22:283-307, 2002.
7. Bjorneklett A, Jenssen E. Relationships between hydrogen (H2) and methane (CH4) production in man. Scand J Gastroenterol 17:985-992, 1982.
8. Savarino V, Vigneri S, Celle G. The 13C urea breath test in the diagnosis of Helicobacter pylori infection. Gut 45:I18-I22, 1999.
9. Zoetendal EG, Akkermans ADL, de Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64:3854-3859, 1998.
10. Hayashi H, Sakamoto M, Benno Y. Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol 46:535-548, 2002.
11. Duncan AM, Phipps WR, Kurzer MS. Phyto-oestrogens. Best Pract Res Clin Endocrinol Metab 17:253-271, 2003.
12. Reinli K, Block G. Phytoestrogen content of foods-a compendium of literature values. Nutr Cancer 26:123-148, 1996.
13. Liu Z, Li W, Sun J, Liu C, Zeng Q, Huang J, Yu B, Huo J. Intake of soy foods and soy isoflavones by rural adult women in China. Asia Pac J Clin Nutr 13:204-209, 2004.
14. Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst 95:906-913, 2003.
15. Atkinson C, Skor HE, Fitzgibbons ED, Scholes D, Chen C, Wähälä K, Schwartz SM, Lampe JW. Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake. Cancer Epidemiol Biomarkers Prev 11:253-260, 2002.
16. Keinan-Boker L, Peeters PH, Mulligan AA, Navarro C, Slimani N, Mattisson I, Lundin E, McTaggart A, Allen NE, Overvad K, Tjonneland A, Clavel-Chapelon F, Linseisen J, Haftenberger M, Lagiou P, Kalapothaki V, Evangelista A, Frasca G, Bueno-de-Mesquita HB, van der Schouw YT, Engeset D, Skeie G, Tormo MJ, Ardanaz E, Charrondiere UR, Riboli E. Soy product consumption in 10 European countries: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 5:1217-1226, 2002.
17. Setchell KDR. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68(Suppl):1333S-1346S, 1998.
18. Lamartiniere CA. Timing of exposure and mammary cancer risk. J Mammary Gland Biol Neoplasia 7:67-76, 2002.
19. Shu XO, Jin F, Dai Q, Wen W, Potter JD, Kushi LH, Ruan Z, Gao YT, Zheng W. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 10:483-488, 2001.
20. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23:1491-1496, 2002.
21. Heinonen S, Wähälä K, Adlercreutz H. Identification of isoflavone metabolites dihydrodaidzein, dihydrogenistein, 6′-OH-O-dma, and cis-4-OH-equol in human urine by gas chromatography-mass spectroscopy using authentic reference compounds. Anal Biochem 274:211-219, 1999.
22. Heinonen SM, Hoikkala A, Wahala K, Adlercreutz H. Metabolism of the soy isoflavones daidzein, genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton. J Steroid Biochem Mol Biol 87:285-299, 2003.
23. Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, Arai Y, Mazur W, Wähälä K, Adlercreutz H. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr 128:1710-1715, 1998.
24. Morton MS, Chan PSF, Cheng C, Blacklock N, Matos-Ferreira A, Abranches-Monteiro L, Correia R, Lloyd S, Griffiths K. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate 32:122-128, 1997.
25. Franke AA, Custer LJ, Wilkens LR, Le Marchand LL, Nomura AM, Goodman MT, Kolonel LN. Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci 777:45-59, 2002.
26. Maubach J, Bracke ME, Heyerick A, Depypere HT, Serreyn RF, Mareel MM, De Keukeleire D. Quantitation of soy-derived phytoestrogens in human breast tissue and biological fluids by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 784:137-144, 2003.
27. Maubach J, Depypere HT, Goeman J, Van der Eycken J, Heyerick A, Bracke ME, Blondeel P, De Keukeleire D. Distribution of soy-derived phytoestrogens in human breast tissue and biological fluids. Obstet Gynecol 103:892-898, 2004.
28. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Mori M. Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration. Jpn J Clin Oncol 32:296-300, 2002.
29. Kelly GE, Joannou GE, Reeder AY, Nelson C, Waring MA. The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med 208:40-43, 1995.
30. Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 217:335-339, 1998.
31. Hutchins AM, Slavin JL, Lampe JW. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J Am Diet Assoc 95:545-551, 1995.
32. Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, Adlercreutz H, Watanabe S. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 10:127-135, 2000.
33. Frankenfeld CL, McTiernan A, Tworoger SS, Atkinson C, Thomas WK, Stanczyk FZ, Marcovina SM, Weigle DS, Weiss NS, Holt VL, Schwartz SM, Lampe JW. Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes. J Steroid Biochem Mol Biol 88:399-408, 2004.
34. Lundh T. Metabolism of estrogenic isoflavones in domestic animals. Proc Soc Exp Biol Med 208:33-39, 1995.
35. Adlercreutz H, Musey PI, Fotsis T, Bannwart C, Wähälä K, Mäkelä T, Brunow G, Hase T. Identification of lignans and phytoestrogens in urine of chimpanzees. Clin Chim Acta 158:147-154, 1986.
36. Juniewicz PE, Pallante Morell S, Moser A, Ewing LL. Identification of phytoestrogens in the urine of male dogs. J Steroid Biochem 31:987-994, 1988.
37. Monfort SL, Thompson MA, Czekala NM, Kasman LH, Shackleton CH, Lasley BL. Identification of a non-steroidal estrogen, equol, in the urine of pregnant macaques: correlation with steroidal estrogen excretion. J Steroid Biochem 20:869-876, 1984.
38. Blair RM, Appt SE, Franke AA, Clarkson TB. Treatment with antibiotics reduces plasma equol concentration in cynomolgus monkeys (Macaca fascicularis). J Nutr 133:2262-2267, 2003.
39. Blair RM, Appt SE, Bennetau-Pelissero C, Clarkson TB, Anthony MS, Lamothe V, Potter SM. Dietary soy and soy isoflavones have gender-specific effects on plasma lipids and isoflavones in golden Syrian f(1)b hybrid hamsters. J Nutr 132:3585-3591, 2002.
40. Ohta A, Uehara M, Sakai K, Takasaki M, Adlercreutz H, Morohashi T, Ishimi Y. A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice. J Nutr 132:2048-2054, 2002.
41. Brown NM, Setchell KD. Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones. Lab Invest 81:735-747, 2001.
42. Lamartiniere CA, Wang J, Smith-Johnson M, Eltoum IE. Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol Sci 65:228-238, 2002.
43. Bayer T, Colnot T, Dekant W. Disposition and biotransformation of the estrogenic isoflavone daidzein in rats. Toxicol Sci 62:205-211, 2001.
44. Cruz MLA, Wong WW, Mimouni F, Hachey DL, Setchell KDR, Klein PD, Tsang RC. Effects of infant nutrition on cholesterol synthesis rates. Pediatric Res 35:135-140, 1994.
45. Rowland I, Wiseman H, Sanders T, Adlercreutz H, Bowey E. Metabolism of oestrogens and phytoestrogens: role of the gut microflora. Biochem Soc Trans 27:304-308, 1999.
46. Atkinson C, Berman S, Humbert O, Lampe JW. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. J Nutr 134:596-599, 2004.
47. Rowland IR, Wisemen H, Sanders TAB, Adlercreutz H, Bowey EA. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36:27-32, 2000.
48. Frankenfeld CL, Atkinson C, Thomas WK, Goode EL, Gonzalez A, Jokela T, Wähälä K, Schwartz SM, Li SS, Lampe JW. Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Exp Biol Med 229:902-913, 2004.
49. Hur HG, Beger RD, Heinze TM, Lay JO Jr, Freeman JP, Dore J, Rafii F. Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein. Arch Microbiol 178:8-12, 2002.
50. Schoefer L, Mohan R, Braune A, Birringer M, Blaut M. Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol Lett 208:197-202, 2002.
51. Blaut M, Schoefer L, Braune A. Transformation of flavonoids by intestinal microorganisms. Int J Vitam Nutr Res 2:79-87, 2003.
52. Tsangalis D, Ashton JF, McGill AEJ, Shah NP. Enzymic transformation of isoflavone phytoestrogens in soymilk by B -glucosidase-producing Bifidobacteria. J Food Sci 67:3104-3113, 2002.
53. Hur HG, Lay JO Jr, Beger RD, Freeman JP, Rafii F. Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch Microbiol 174:422-428, 2000.
54. Ueno T, Uchiyama S, Kikuchi N. The role of intestinal bacteria on biological effects of soy isoflavones in humans. J Nutr 132:594S, 2002.
55. Frankenfeld CL, McTiernan A, Aiello EJ, Thomas WK, LaCroix K, Schramm J, Schwartz SM, Holt VL, Lampe JW. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women. Cancer Epidemiol Biomarkers Prev 13:1156-1162, 2004.
56. 13C- labeled tracers in premenopausal women. Am J Clin Nutr 77:411-419, 2003.
57. Setchell KDR, Bordello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 40:569-578, 1984.
58. King RA, Mano MM, Head RJ. Assessment of isoflavonoid concentrations in Australian bovine milk samples. J Dairy Res 65:479-489, 1998.
59. Antignac JP, Cariou R, Le Bizec B, Cravedi JP, Andre F. Identification of phytoestrogens in bovine milk using liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom 17:1256-1264, 2003.
60. Bonorden MJ, Greany KA, Wangen KE, Phipps WR, Feirtag J, Adlercreutz H, Kurzer MS. Consumption of Lactobacillus acidophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women. Eur J Clin Nutr 58:1635-1642, 2004.
61. Duncan AM, Merz-Demlow BE, Xu X, Phipps WR, Kurzer MS. Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev 9:581-586, 2000.
62. Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP, Dowsett M, Welch AA, Khaw KT, Wareham NJ, Day NE, Bingham SA. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev 13:698-708, 2004.
63. Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hämäläinen E, Hasegawa T, Okada H. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 54:1093-1100, 1991.
64. Lampe JW, Skor HE, Li S, Wähälä K, Howald WN, Chen C. Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women. J Nutr 131:740-744, 2001.
65. Kirkman LM, Lampe JW, Campbell DR, Martini MC, Slavin JL. Urinary lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets. Nutr Cancer 24:1-12, 1995.
66. Karr SC, Lampe JW, Hutchins AM, Slavin JL. Urinary isoflavonoid excretion in humans is dose-dependent at low to moderate levels of soy protein consumption. Am J Clin Nutr 66:46-51, 1997.
67. Kelly GE, Nelson C, Waring MA, Joannou GE, Reeder AY. Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 223:9-22, 1993.
68. Lu LJ, Anderson KE. Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans. Am J Clin Nutr 68:1500S-1504S, 1998.
69. Maskarinec G, Williams AE, Inouye JS, Stanczyk FZ, Franke AA. A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol Biomarkers Prev 11:195-201, 2002.
70. Flatz G, Czeizel A, Metneki J, Flatz SD, Kuhnau W, Jahn D. Pulmonary hydrogen and methane excretion following ingestion of an unabsorbable carbohydrate: a study of twins. J Pediatr Gastroenterol Nutr 4:936-941, 1985.
71. Van de Merwe JP, Stegeman JH, Hazenberg MP. The resident faecal flora is determined by genetic characteristics of the host. Implications for Crohn's disease? Antonie Van Leeuwenhoek 49:119-124, 1983.
72. Markiewicz L, Garey J, Adlercreutz H, Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 45:399-405, 1993.
73. Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 12:1559-1567, 2004.
74. Kinjo J, Tsuchihashi R, Morito K, Hirose T, Aomori T, Nagao T, Okabe H, Nohara T, Masamune Y. Interactions of phytoestrogens with estrogen receptors alpha and beta (III). Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine. Biol Pharm Bull 27:185-188, 2004.
75. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, Masamune Y. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 24:351-356, 2001.
76. Sathyamoorthy N, Wang TTY. Differential effects of dietary phytooestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur J Cancer 33:2384-2389, 1997.
77. Kostelac D, Rechkemmer G, Briviba K. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J Agric Food Chem 51:7632-7635, 2003.
78. Selvaraj V, Zakroczymski MA, Naaz A, Mukai M, Ju YH, Doerge DR, Katzenellenbogen JA, Helferich WG, Cooke PS. Estrogenicity of the isoflavone metabolite equol on reproductive and non-reproductive organs in mice. Biol Reprod 71:966-972, 2004.
79. Vedavanam K, Srijayanta S, O'Reilly J, Raman A, Wiseman H. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res 13:601-608, 1999.
80. Arora A, Nair MG, Strasburg GM. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys 356:133-141, 1998.
81. Rimbach G, De Pascual-Teresa S, Ewins BA, Matsugo S, Uchida Y, Minihane AM, Turner R, VafeiAdou K, Weinberg PD. Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica 33:913-925, 2003.
82. Turner R, Baron T, Wolffram S, Minihane AM, Cassidy A, Rimbach G, Weinberg PD. Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radic Res 38:209-216, 2004.
83. Nagel SC, vom Saal FS, Welshons WV. The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity. Proc Soc Exp Biol Med 217:300-309, 1998.
84. Liew R, Williams JK, Collins P, MacLeod KT. Soy-derived isoflavones exert opposing actions on Guinea pig ventricular myocytes. J Pharmacol Exp Ther 304:985-993, 2003.
85. Hedlund TE, Johannes WU, Miller GJ. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate 54:68-78, 2003.
86. Di Virgilio AL, Iwami K, Watjen W, Kahl R, Degen GH. Genotoxicity of the isoflavones genistein, daidzein and equol in V79 cells. Toxicol Lett 151:151-162, 2004.
87. Schmitt E, Metzler M, Jonas R, Dekant W, Stopper H. Genotoxic activity of four metabolites of the soy isoflavone daidzein. Mutat Res 542:43-48, 2003.
88. Schmitt E, Dekant W, Stopper H. Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues. Toxicol In Vitro 15:433-439, 2001.
89. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595, 1987.
90. Barnes S, Peterson TG, Coward L. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem Suppl 22:181-187, 1995.
91. Picherit C, Coxam V, Bennetau-Pelissero C, Kati-Coulibaly S, Davicco MJ, Lebecque P, Barlet JP. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 130:1675-1681, 2000.
92. Lund TD, Munson DJ, Haldy ME, Setchell KD, Lephart ED, Handa RJ. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reprod 70:1188-1195, 2004.
93. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132:3577-3584, 2002.
94. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ, Cheng J, Gao YT, Zheng W. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 11:815-821, 2002.
95. Zheng W, Dai Q, Custer LJ, Shu XO, Wen WQ, Jin F, Franke AA, Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarker Prev 8:35-40, 1999.
96. Wu AH, Yu MC, Tseng CC, Twaddle NC, Doerge DR. Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County. Carcinogenesis 25:77-81, 2004.
97. Miyanaga N, Akaza H, Takashima N, Nagata Y, Sonoda T, Mori M, Naito S, Hirao Y, Tsukamoto T, Fujioka T. Higher consumption of green tea may enhance equol production. Asian Pac J Cancer Prev 4:297-301, 2003.
98. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Fujioka T, Mori M, Kim WJ, Song JM, Pantuck AJ. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34:86-89, 2004.
99. Ozasa K, Nakao M, Watanabe Y, Hayashi K, Miki T, Mikami K, Mori M, Sakauchi F, Washio M, Ito Y, Suzuki K, Wakai K, Group AT. Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci 95:65-71, 2004.
100. Hong SJ, Kim SI, Kwon SM, Lee JR, Chung BC. Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Yonsei Med J 43:236-241, 2002.
101. Kim MK, Chung BC, Yu VY, Nam JH, Lee HC, Huh KB, Lim SK. Relationships of urinary phyto-oestrogen excretion to BMD in postmenopausal women. Clin Endocrinol (Oxf) 56:321-328, 2002.
102. Allred CD, Allred KF, Ju YH, Goeppinger TS, Doerge DR, Helferich WG. Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 25:1649-1657, 2004.
103. Messina M. Western soy intake is too low to produce health effects. Am J Clin Nutr 80:528-529, 2004.
104. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 350:990-994, 1997.
105. Messina M, Barnes S, Setchell K. Phyto-oestrogens and breast cancer (letter). Lancet 350:971-972, 1997.
106. Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schünemann HJ, Stanulla M, Yang J, Sepkovic DW, Trevisan M, Berrino F. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16 alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology 11:635-640, 2000.
107. Kabat GC, Chang CJ, Sparano JA, Sepkovie DW, Hu XP, Khalil A, Rosenblatt R, Bradlow HL. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomark Prev 6:505-509, 1997.
108. Meilahn EN, De Stavola B, Allen DS, Fentiman I, Bradlow HL, Sepkovic DW, Kuller LH. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. Br J Cancer 78:1250-1255, 1998.
109. Zheng W, Dunning L, Jin F, Holtzman J. Correspondence re: G. C. Kabat et al. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomark Prev 7:85-86, 1998.
110. Atkinson C, Skor HE, Fitzgibbons ED, Scholes D, Chen C, Wahala K, Schwartz SM, Lampe JW. Urinary equol excretion in relation to 2-hydroxyestrone and 16a-hydroxyestrone concentrations: an observational study of young to middle-aged women. J Steroid Biochem Mol Biol 86:71-77, 2003.
111. Kardinaal AF, Morton MS, Brüggemann-Rotgans IE, van Beresteijn EC. Phyto-oestrogen excretion and rate of bone loss in postmenopausal women. Eur J Clin Nutr 52:850-855, 1998.
112. de Kleijn MJJ, van der Schouw YT, Wilson PWF, Adlercreutz H, Mazur W, Grobbee DE, Jacques PF. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham Study. J Nutr 131:1826-1832, 2001.
113. Frankenfeld CL, Patterson RE, Homer NK, Neuhouser ML, Skor HE, Kalhom TF, Howald WN, Lampe JW. Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women. Am J Clin Nutr 77:674-680, 2003.
114. Cassidy A, Bingham S, Setchell KDR. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 60:333-340, 1994.
115. Meyer BJ, Larkin TA, Owen AJ, Astheimer LB, Tapsell LC, Howe PR. Limited lipid-lowering effects of regular consumption of whole soybean foods. Ann Nutr Metab 48:67-78, 2004.
116. Howes JB, Sullivan D, Lai N, Nestel P, Pomeroy S, West L, Eden JA, Howes LG. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 152:143-147, 2000.
117. Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr 78:123-130, 2003.
118. Kreijkamp-Kaspers S, Kok L, Grobbee DE, de Haan EH, Aleman A, Lampe JW, van der Schouw YT. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 292:65-74, 2004.
119. Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA 290:207-214, 2003.
120. Persky VW, Turyk ME, Wang L, Freels S, Chatterton R Jr, Barnes S, Erdman JW Jr, Sepkovic DW, Bradlow HL, Potter SM. Effect of soy protein on endogenous hormones in postmenopausal women. Am J Clin Nutr 75:145-153, 2002.
121. Boyd NF, Lockwood GA, Martin LJ, Byng JW, Yaffe MJ, Tritchler DL. Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. IARC Sci Publ 154:163-169, 2001.
122. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomark Prev 7:1133-1144, 1998.
123. Evans BA, Griffiths K, Morton MS. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 147:295-302, 1995.
124. Pelissero C, Lenczowski MJ, Chinzi D, Davail-Cuisset B, Sumpter JP, Fostier A. Effects of flavonoids on aromatase activity, an in vitro study. J Steroid Biochem Mol Biol 57:215-223, 1996.
125. Adlercreutz H, Bannwart C, Wähälä K, Mäkelä T, Brunow G, Hase T, Arosemena PJ, Kellis JTJ, Vickery LE. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44:147-153, 1993.
126. Harris RM, Wood DM, Bottomley L, Blagg S, Owen K, Hughes PJ, Waring RH, Kirk CJ. Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment. J Clin Endocrinol Metab 89:1779-1787, 2004.
127. Järvenpää P, Kosunen T, Fotsis T, Adlercreutz H. In vitro metabolism of estrogens by isolated intestinal micro-organisms and by human faecal microflora. J Steroid Biochem 13:345-349, 1980.
128. Adlercreutz H, Martin F, Lehtinen T, Tikkanen M, Pulkkinen M. Effect of ampicillin administration on plasma conjugated and unconjugated estrogen and progesterone levels in pregnancy. Am J Obstet Gynecol 128:266-271, 1977.
129. Adlercreutz H, Martin F, Pulkkinen M, Dencker H, Rimer U, Sjöberg N-O, Tikkanen MJ. Intestinal metabolism of estrogens. J Clin Endocrinol Metab 43:497-505, 1976.
130. Martin F, Peltonen J, Laatikainen T, Pulkkinen M, Adlercreutz H. Excretion of progesterone metabolites and estriol in faeces from pregnant women during ampicillin administration. J Steroid Biochem 6:1339-1346, 1975.
131. Tikkanen M, Pulkkinen M, Adlercreutz H. Effect of ampicillin treatment on the urinary excretion of estriol conjugates in pregnancy. J Steroid Biochem 4:439-440, 1973.
132. Willman K, Pulkkinen M. Reduced maternal plasma and urinary estriol during ampicillin treatment. Am J Obstet Gynecol 109:893-896, 1971.
133. Jensen J, Liljemark W, Bloomquist C. The effect of female sex hormones on subgingival plaque. J Periodontol 52:599-602, 1981.
134. Nakagawa S, Fujii H, Machida Y, Okuda K. A longitudinal study from prepuberty to puberty of gingivitis. Correlation between the occurrence of Prevotella intermedia and sex hormones. J Clin Periodontol 21:658-665, 1994.
135. Muramatsu M, Takaesu Y. Oral health status related to subgingival bacterial flora and sex hormones in saliva during pregnancy. Bull Tokyo Dent Coll 35:139-151, 1994.
136. Zoetendal EG, Akkermans ADL, Akkermans-van Vliet WM, de Visser JAGM, de Vos WM. The host genotype affects the bacterial community in the human gastrointestinal tract. Microb Ecol Health Dis 13:129-134, 2001.
137. Malaty HM, Engstrand L, Pedersen NL, Graham DY. Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med 120:982-986, 1994.
138. Mai V, Morris JG, Jr. Colonic bacterial flora: changing understandings in the molecular age. J Nutr 134:459-464, 2004.